These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14578763)

  • 1. Cyclosporine withdrawal in stable renal transplant recipients.
    Mahawar KK
    Transplantation; 2003 Oct; 76(8):1240-1. PubMed ID: 14578763
    [No Abstract]   [Full Text] [Related]  

  • 2. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
    Goldfarb DA
    J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Cyclosporine-sparing' regimen approved.
    Am J Nurs; 2003 Jul; 103(7):64F. PubMed ID: 12877131
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cylosporine posological individualization strategies in renal transplant patients].
    Porta B; Pérez Ruixo JJ; Jiménez Torres NV; Crespo J
    Nefrologia; 2004; 24(5):395-409. PubMed ID: 15648900
    [No Abstract]   [Full Text] [Related]  

  • 7. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO; Dias MF; Pacheco-Silva A
    Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [News from transplantation medicine. Less rejection thanks to new monitoring].
    MMW Fortschr Med; 2000 Nov; 142(44):54. PubMed ID: 11107813
    [No Abstract]   [Full Text] [Related]  

  • 9. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
    Ingsathit A; Sumethkul V; Chalermsanyakorn P; Jirasiritham S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S235-41. PubMed ID: 17044477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New regimen for kidney transplants.
    FDA Consum; 2003; 37(4):4. PubMed ID: 12971328
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
    Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventing rejection, minimizing toxicity: optimized therapy with cyclosporin].
    MMW Fortschr Med; 2002 Jan; 144(3-4):59. PubMed ID: 11862796
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions.
    Augustine JJ; Hricik DE
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1080-9. PubMed ID: 17699329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients.
    Kosch M; Hausberg M; Suwelack B
    Transplantation; 2003 Nov; 76(10):1516-9. PubMed ID: 14657697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variation of cyclosporine clearance in stable renal transplant recipients receiving continuous infusion.
    Heifets M; Cooney GF; Shaw LM; Libetti G
    Transplantation; 1995 Dec; 60(12):1615-7. PubMed ID: 8545900
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there a rationale to combine cyclosporin and sirolimus?
    Kahan BD
    Nephrol Dial Transplant; 1996 Jan; 11(1):21-3. PubMed ID: 8649641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.